FDA enforcement report year
2023 FDA peptide enforcement reports
1 dated report mapped only through exact reviewed application-number annotations.
2023-10-04 · Class III · Terminated
Leuprolide · Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Open attributed report →